Kaempferol Attenuates Myocardial Ischemic Injury<i> via</i> Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury

<div>Effect of KMP on ((a1)–(d1)) Bcl-2 immunohistochemistry (20x; scale bar 100 <i>μ</i>m); ((a2)–(d2)) Bax immunohistochemistry (20x; scale bar 100 <i>μ</i>m); ((a3)–(d3)) Caspase-3 immunohistochemistry (20x; scale bar 100 <i>μ</i>m); ((a4)–(d4)) TUNEL positivity (20x; scale bar 100 <i>μ</i>m). ((a1)–(a4)) Sham; ((b1)–(b4)) ischemia-reperfusion control; ((c1)–(c4)) kaempferol 20 mg/kg/day + ischemia-reperfusion; ((d1)–(d4)) kaempferol 20 mg/kg/day<i> per se</i>.</div>

Oxidative Medicine and Cellular Longevity

fig2

Figure 2

Figure 2: Kaempferol Attenuates Myocardial Ischemic Injury<i> via</i> Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury 

Figure 2 | Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury 